On the Significance of Antiviral Combinations to Treat COVID-19: Polymerase Plus Protease Inhibitors

In this manuscript we argue that the use of Sofosbuvir as a possible medication in the clinical treatment of COVID-19 can be complemented with HCV protease inhibitors given the homology between the HCV NS3/4A protease and the SARS-CoV-2 Mpro protease.